|
| | HR0040 | | LRB100 05054 MST 15064 r |
|
|
1 | | HOUSE RESOLUTION
|
2 | | WHEREAS, According to Dysautonomia International, |
3 | | Dysautonomia is an umbrella term used to
describe several |
4 | | different medical conditions that cause a malfunction of the |
5 | | Autonomic Nervous
System (ANS); and
|
6 | | WHEREAS, The ANS is responsible for controlling the |
7 | | "automatic" functions of the human body,
including, but not |
8 | | limited to, heart rate, blood pressure, and kidney function; |
9 | | and
|
10 | | WHEREAS, Various types of Dysautonomia result in the |
11 | | inability of the body to regulate these systems
which may lead |
12 | | to lightheadedness, fainting, unstable blood pressure, |
13 | | abnormal heart rates,
malnutrition, and even in some cases |
14 | | death; and
|
15 | | WHEREAS, Over 70 million people worldwide of all ages, |
16 | | gender, and race have some type of
Dysautonomia; and
|
17 | | WHEREAS, There is no known cure for Dysautonomia, but |
18 | | various groups
including Dysautonomia International continue |
19 | | to fund research in the hopes of finding a cure and
treatment |
20 | | for each type of Dysautonomia; and
|